News

More than 30 projects were submitted for the 1st Immunis Sponsorship for Young Science, and prizes were awarded during the ÖGAI annual meeting. Sarah Spöck from the Medical University Innsbruck received the Immunis Sponsorship for Young Science 2021 and will be supported in her research with cash and in-kind contributions worth 7,000 euros. The recognition award endowed with 1,000 euros is awarded to Mustahpa Jaiteh from CeMM.

Lonza's "Classic Media" product line will be removed from the range at the end of 2021. But don't worry, we have alternatives for you.

When there is an increased risk of infection, crowds of people or clusters of infections, rapid certainty about the incidence of new infections is essential. With the first test and laboratory bus, the Office of Armaments and Defense Technology relies on a fully equipped mobile laboratory.

Life science research distributor Nordic BioSite Group acquires Austrian Szabo Scandic to further expand geographical footprint – with ultimate goal of becoming an even stronger partner to its suppliers and customers.

We offer an extensive range of research reagents to support the SARS-CoV-2 studies. Please see below the products for SARS-CoV-2 research, from antibodies to proteins and additional reagents like viral transport medium or ELISA kit to measure cytokine storm. For the detection of SARS-CoV-2, we have ELISA and PCR kits as well as an antibody rapid test.

Nordic-MUbios’ mouse anti double-stranded RNA antibody (clone J2) was used in crucial research to identify potent therapeutic agents to impede SARS-CoV-2 viral entry into host cells. SARS-CoV-2, better known as COVID-19, is a positive-strand RNA virus.

Serum-free cell culture is a cutting-edge topic in research. Find out here where the advantages of this access lie and what you should pay attention to.

Ever-evolving biological research requires tools that are not always easily and commercially available. For a researcher, that challenge can be difficult for a variety of reasons: material procurement, technical knowledge, capacity and the risk of production downtime.

When was the last time you tested? Not yourself, but your cell culture? Mycoplasma contamination is a well-known but still often ignored problem in cell culture. Currently, only about 30% of cell culture labs test for mycoplasma.

90 drugs received marketing authorization in the EU in 2020, and a further 27 in the first quarter of 2021. The majority of therapies were registered in the field of oncology – comparable to previous years. However, Covid-19 reversed this trend. In 2021, private and public research institutions in Austria expect a particularly large number of publications on vaccines and drugs for infectious diseases.